Current Opinion in Clinical Nutrition and Metabolic Care was launched in 1998. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of clinical nutrition and metabolic care are divided into 13 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue.
Vickie E. Baracos PhD
Dr. Baracos received her PhD in Applied Biochemistry and Nutrition at the University of Nottingham (England) in 1981, and thereafter was a postdoctoral fellow with Dr Alfred L Goldberg at Harvard University (USA) until 1984. Dr Baracos joined the Department of Agricultural Food & Nutritional Science at the University of Alberta (Canada) in 1984, and was recently appointed to the Alberta Cancer Foundation Chair in Palliative Medicine in the Department of Oncology, University of Alberta.
Dr Baracos' research program on muscle and protein metabolism spans two decades and is related to different physiologic and pathologic states where muscle protein growth or wasting occur, including cancer, chemotherapy, sepsis, injury, diabetes, and lactation.
Dr Baracos has had a long history with anabolic and catabolic mediators, starting with the first observation that a cytokine, Interleukin-1, had a direct action to increase protein catabolism in skeletal muscle, published in 1983 in the New England Journal of Medicine. This described the first tangible link between inflammation, infection and injury and muscle wasting. The role of pro-inflammatory cytokines as “cachectins” has subsequently become developed and these are now believed to be key factors underlying various forms of wasting. Dr Baracos' current focus is cancer-associated muscle wasting and her work spans the cellular and molecular aspects of muscle wasting, the identity of factors that provoke muscle wasting, and the application of nutritional treatments to reduce wasting.
Jean-Paul Thissen, MD, PhD
Dr Jean-Paul Thissen is Professor of Medicine in the division of Endocrinology and Nutrition at the Catholic University of Louvain (Brussels, Belgium). He obtained his MD degree in 1983 and completed his residency in the same university. During his post-doctoral training, he spent three years working in the laboratory of Louis E. Underwood at the University of North Carolina at Chapel Hill. The major focus of Dr Thissen's laboratory is to investigate the mechanisms of regulation of growth factors, in particular the Insulin-like Growth factors, production and action by nutrients and cytokines. Major emphasis is now directed at determining the role of IGF-I in the molecular mechanisms responsible for muscle atrophy in catabolic situations. He is funded by the National Belgian Scientific Foundation. Dr Thissen published 70 articles, reviews and book chapters. He is member of several scientific and professional societies in endocrinology and nutrition.
Professor Gil Hardy PhD FRSC
Gil Hardy trained as a Biochemist, with degrees from Bristol and Cambridge Universities. He subsequently worked in Belgium and Germany, then in 1982 began post-doctoral research with Nobel Prize Winner, the late Professor Sir Hans Krebs at the Metabolic Research Laboratory, University of Oxford.
In 1977 Gil developed the first 3 litre TPN bag to be used clinically in the UK. Subsequently he has pioneered work on the stability of amino acids and micro-nutrients in oxygen-impermeable plastics for improving long term stability of All-In-One TPN mixtures. He was the first in Europe to produce stable L-Glutamine intravenous solutions (G Hardy et al. The Lancet 1993, Vol 342: 186) and more recently lyophilised L-Glutamine-enriched amino acid mixtures. These products have been used for major clinical investigations demonstrating improved outcome for the critically ill over the last few years. (R Griffiths et al. Nutrition 1997, 13:296-302.G Hardy et al. Clinical Nutrition 2003, S102)
In 1998 Dr Hardy was appointed Professor of Pharmaceutical Nutrition in the School of Biological and Molecular Sciences at Oxford Brookes University where he expanded his research interests and helped develop new courses in Clinical Nutrition. He is now Chairman of Oxford Nutrition conducting collaborative pharmaceutical and metabolic research with Glutamine, Glutathione, Selenium and other nutrients/antioxidants with colleagues in Oxford, Auckland and other Academic Centres around the world (E Valencia et al. Curr Opin Clin Nutr Metab Care 2002, 5: 321-326).
Professor Hardy is a founder member of the British Pharmaceutical Nutrition Group, who in 2002 established the annual ‘Allwood-Hardy’ lecture jointly in his honour. He edits the BPNG newsletter ‘Feeding Times’ and represents this Pharmacy Group on the Scientific & Research Committee of the British Association of Parenteral and Enteral Nutrition. Gil was also one of the original tutors for the BAPEN Educational Course for Nutrition Support Teams, which he helped to establish.
An active member of ESPEN, SASPEN, ASPEN and SBPNE he has lectured on Glutamine, Antioxidants and Pharmaceutical Issues of Nutrition Support at many of their annual Congresses. He serves on the Editorial Advisory Board of “On-line”, the UK Home patients Newsletter, is a Section Editor for ‘Current Opinion in Clinical Nutrition and Metabolic Care’ and edits the “Nutraceuticals” column for the international journal “Nutrition”.
In all Professor Gil Hardy has presented approximately 150 posters, papers and educational lectures in the field of Clinical Nutrition. He is recognised as a world authority on the pharmaceutical and metabolic properties of Glutamine and is the founder and organiser of the internationally acclaimed Oxford Glutamine Workshops (Nutrition 2002, 18: 1-10).
Antonio Campos, MD, PhD
Antonio Carlos Campos was born in 1957 in Curitiba, Brazil. He graduated in the Medical School of the Federal University of Parana in Curitiba, Brazil, in 1980. After finishing his Residency in General Surgery, he spent a year in Montpellier, France, with Professor Henri Joyeux. During this period his interest for Clinical nutrition was stimulated through his participation in several clinical and experimental investigations largely focusing on parenteral nutrition. In particular he worked with the influence of parenteral lipid emulsions on the liver regeneration after partial hepatectomy in dogs. Upon returning to Brazil, he obtained a Master's Degree in Clinical Surgery in 1987, working with dogs subjected to total colectomy and ileal reservoirs. At the end of 1987 he went to Syracuse, NY, as a Research Fellow at the State University of New York, under the guidance of Professor Michael Meguid. This was a very productive period. Dr. Campos participated of a number of clinical and experimental investigations covering a wide range of subjects in nutrition, including cancer, control of food intake and perioperative nutrition. After returning to Brazil he was accepted in a Ph.D. Program in Clinical Surgery, and his Ph.D. Degree was obtained in 1992 working with bacterial translocation in rats receiving parenteral nutrition.
In 1996 Dr. Campos became Professor of Surgery at the Federal University of Parana. Presently he is the Director of the Graduate Program in Clinical Surgery at the same University. During his entire career he has devoted a substantial amount of work to nutrition. He has published over 160 papers in National and International Journals and 40 book chapters, mostly on nutrition and surgery. Dr. Campos has over 400 participations in Congresses as speaker. He was President of the Brazilian Society of Parenteral and Enteral Nutrition from 1997-99 and President of the Latin American Federation of Parenteral and Enteral Nutrition (FELANPE) from 1999-2001. Dr. Campos is the Section Editor of the Current Opinion in Clinical Nutrition and Metabolic Care and is the Latin American Editor of NUTRITION since 1994.